Prabhasadanam G. Sadhujan

Prabhasadanam Sadhujan practices at Whitter Westborough Irf Unit in Westborough, Massachusetts.

Prabhasadanam Sadhujan's NPI, 1568415461, was assigned on May 19, 2006. Prabhasadanam Sadhujan holds Massachusetts license 220110.

Prabhasadanam Sadhujan's primary practice is Whitter Westborough Irf Unit, at 150 Flanders Rd, Westborough, MA 01581 in Worcester County. The practice phone is (508) 871-2000.

Prabhasadanam Sadhujan's primary practice is Whitter Westborough Irf Unit in Westborough, Massachusetts. Prabhasadanam Sadhujan is also affiliated with Whittier Rehabilitation Hospital-Westborough. Dmand AI also links Prabhasadanam Sadhujan to 6 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Prabhasadanam Sadhujan practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Prabhasadanam Sadhujan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Prabhasadanam Sadhujan is licensed in Massachusetts.

CMS data shows 2,624 Medicare services from Prabhasadanam Sadhujan across 8 procedure codes in 2024, for 335 Medicare patients. Medicare paid $193,432 for them.

CMS counts 335 Medicare patients who saw Prabhasadanam Sadhujan in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Prabhasadanam Sadhujan's median patient age at 61, with 43% women.

In 2024, Prabhasadanam Sadhujan wrote 2,716 Medicare Part D claims for 236 patients. 86% of them were for generic drugs. CMS names the drug for 2,166 of them, across 60 drugs with 11 or more claims each, at $170,449 in total drug cost. In 2023, CMS named 1,808 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Prabhasadanam Sadhujan for performance year 2024, reported individually. Prabhasadanam Sadhujan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Prabhasadanam Sadhujan as offering telehealth.

CMS Open Payments shows 279 general payments to Prabhasadanam Sadhujan from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $741.